Expert Insights Newsletter by Medical Specialty - Gastroenterology

Photo

Knowing the score: Identifying patients at high risk of liver fibrosis from Non-Alcoholic Fatty Liver Disease (NAFLD)

Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the general population. Patients with its more severe form, nonalcoholic steatohepatitis (NASH), are at significant risk for developing end-stage liver disease. Strongly associated with obesity and type 2 diabetes,... Read more 

Photo

Proton-pump Inhibitors - A Strategy For Reducing Inappropriate Use

Proton-pump inhibitors (PPIs) are the leading therapy for upper gastrointestinal disorders, but their overutilization and inappropriate use is exposing patients to a range of potential risks.1 Dr. Aamir Ali, Assistant Professor of Medicine, George Washington University, discusses the growing concern... Read more 

Photo

The Role of Interferon-Gamma Release Assays (IGRAs) in the Diagnosis of Tuberculosis

World TB Day, taking place on March 24, 2013, is an annual reminder of the global burden of tuberculosis (TB), raising awareness of efforts to control and prevent the disease.1 While TB mortality has fallen over 40% worldwide since 1990,... Read more 

Photo

Hepatitis — Diagnostic Advances Help Guide New Therapies

An estimated 4.4 million Americans are living with chronic hepatitis - the majority unaware they are infected. Approximately 30% have chronic Hepatitis B (HBV) infection, and 70% have chronic Hepatitis C (HCV). It is estimated that about 80,000 new infections... Read more 

Photo

Disaccharidase Deficiency: An Overlooked Digestive Disorder

Disaccharidases are enzymes the break down complex sugars (like lactose) into simple sugars (like glucose) so that the intestine can absorb the nutrients. A deficiency of these enzymes in the duodenum results in a range of gastrointestinal symptoms. The common... Read more